Concepedia

Francesca Buontempo

FB

Statistics

Publications

16

Citations

715

H-Index

15

Active since

2003

Affiliations

University of Bologna(Current)

National Research Council

East Carolina University

University of Urbino

University of Ferrara

Francesca Buontempo is an author at University of Bologna specializing in medicine, cell biology, and cell signaling.

ORCID

Top concepts

Publications per year

2003–2019

16

Publications

16

Cytotoxic activity of the casein kinase 2 inhibitor CX-4945 against T-cell acute lymphoblastic leukemia: targeting the unfolded protein response signaling

Francesca Buontempo, Ester Orsini, Leila R. Martins et al. · Leukemia · 2013 · 81 citations · Full text

, , +10

Activity of the pan-class I phosphoinositide 3-kinase inhibitor NVP-BKM120 in T-cell acute lymphoblastic leukemia

Annalisa Lonetti, Inês Lopes Antunes, Francesca Chiarini et al. · Leukemia · 2013 · 71 citations · Full text

, , +5

Harnessing the PI3K/Akt/mTOR pathway in T-cell acute lymphoblastic leukemia: Eliminating activity by targeting at different levels

Daniela Bressanin, Camilla Evangelisti, Francesca Ricci et al. · Oncotarget · 2012 · 71 citations · Full text

Tyrosol prevents apoptosis in irradiated keratinocytes

Sara Salucci, Sabrina Burattini, Michela Battistelli et al. · Journal of Dermatological Science · 2015 · 64 citations

, , +7

Improving nelarabine efficacy in T cell acute lymphoblastic leukemia by targeting aberrant PI3K/AKT/mTOR signaling pathway

Annalisa Lonetti, Alessandra Cappellini, Alice Bertaina et al. · Journal of Hematology & Oncology · 2016 · 62 citations · Full text

1–5 of 16